Olink

Olink®
Part of Thermo Fisher Scientific

Targeted proteomics reveals immune protein patterns in serum from patients with calcific aortic stenosis

iScience, 2025

Mallia A., Binatti A., Sangiorgi D., Mikus E., Papaianni G., Ghilardi S., Gianazza E., Dalla Sega F., Tremoli E., Banfi C.

Disease areaApplication areaSample typeProducts
CVD
Pathophysiology
Patient Stratification
Serum
Olink Target 96

Olink Target 96

Abstract

Calcific aortic valve disease (CAVD) is progressive condition with poor prognosis once symptomatic. The disease’s progression is driven by a combination of mechanical stress, lipid infiltration, and immune responses, which involve both innate and adaptive immune systems. To explore the role of immune-related proteins in CAVD, we applied a targeted proteomic approach based on the Proximity Extension Assay technique. Ten proteins were downregulated in CAVD patients with respect to control subjects, indicating disrupted biological processes such as redox homeostasis, immune response, and cell motility. A protein-protein interaction network revealed connections between these proteins, with notable clusters associated with immune regulation and redox homeostasis. Further analysis identified two distinct patient subgroups, suggesting heterogeneity among CAVD patients, which could help with patient stratification. The study identified proteins that may serve as candidate biomarkers for early detection of CAVD, and emphasizes the role of immune-driven mechanisms in CAVD.

Read publication ↗